Post job

Quanterix CEO and executives

Executive Summary. Based on our data team's research, E. Kevin Hrusovsky is the Quanterix's CEO. Quanterix has 177 employees, of which 37 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Quanterix executive team is 32% female and 68% male.
  • 68% of the management team is White.
  • 8% of Quanterix management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at Quanterix?
Share your experience

Rate Quanterix's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
E. Kevin Hrusovsky

President, Chairman & CEO

E. Kevin Hrusovsky's LinkedIn

Kevin Hrusovsky is a biotech entrepreneur and healthcare visionary who has dedicated his career to transforming medicine from reactive “sick care” to preventative and personalized healthcare. He catalyzed a precision health movement to promote innovation for eradicating disease and personalizing global health and founded Powering Precision Health, the industry’s leading platform and premier annual forum for advancing the deep science that powers precision health. Hrusovsky has been recognized as a 2017 BBJ Innovation All-Star, a three-time award finalist of the EY Entrepreneur of the Year®, and received the Lifetime Achievement Award for Leadership (2018) and E.G. Bailey Entrepreneurship Award (2013) from The Ohio State University. A dynamic speaker, Hrusovsky regularly participates at leading conferences, including the BIO International Convention, J.P. Morgan Healthcare Conference, PULSE: The Atlantic Summit on Health Care, and MedCity CONVERGE.He currently serves as President, Chairman and CEO of Quanterix, a company digitizing biomarker analysis to advance precision health. In 2017, he took Quanterix public in one of the most successful IPOs for a life science tools company in recent history. Hrusovsky is renowned for his strong track record of launching disruptive technologies, building fast-growing companies, and developing successful commercialization strategies. He lends his business expertise on the boards of several innovative technology companies and serves on the Educational Board of the Massachusetts Biotech Council the JALA Editorial Board, the Strategy Committee of Children’s Hospital Boston and more.Hrusovsky holds an M.B.A. from Ohio University and a B.S. in Mechanical Engineering from The Ohio State University. He received an Honorary Doctorate from Framingham State University and helped build competitive strategy curriculum at the Institute for Strategy & Competitiveness at Harvard Business School. Follow him on Twitter @KevinHrusovsky.

David R. Walt Ph.d

Board Member

Keith L. Crandell

Board Member

Paul M. Meister

Board Member

Nicholas Naclerio

Founder

Martin D. Madaus

Board Member

David C. Duffy

CTO & VP, Research

David C. Duffy's LinkedIn

List of publications

http://www.ncbi.nlm.nih.gov/sites/myncbi/david.duffy.2/bibliography/40539262/public/?sort=date&direction=descending

John J. Fry

General Counsel and Secretary

John J. Fry's LinkedIn

Mark Roskey Ph.d

Senior Vice President

Mark Roskey Ph.d's LinkedIn

Masoud Toloue Ph.d

Chief Executive Officer

Masoud Toloue Ph.d's LinkedIn

Do you work at Quanterix?

Does leadership effectively guide Quanterix toward its goals?

Quanterix jobs

Quanterix founders

Name & TitleBio
David R. Walt Ph.d

Board Member

Keith L. Crandell

Board Member

Paul M. Meister

Board Member

Nicholas Naclerio

Founder

Quanterix board members

Name & TitleBio
E. Kevin Hrusovsky

President, Chairman & CEO

E. Kevin Hrusovsky's LinkedIn

Kevin Hrusovsky is a biotech entrepreneur and healthcare visionary who has dedicated his career to transforming medicine from reactive “sick care” to preventative and personalized healthcare. He catalyzed a precision health movement to promote innovation for eradicating disease and personalizing global health and founded Powering Precision Health, the industry’s leading platform and premier annual forum for advancing the deep science that powers precision health. Hrusovsky has been recognized as a 2017 BBJ Innovation All-Star, a three-time award finalist of the EY Entrepreneur of the Year®, and received the Lifetime Achievement Award for Leadership (2018) and E.G. Bailey Entrepreneurship Award (2013) from The Ohio State University. A dynamic speaker, Hrusovsky regularly participates at leading conferences, including the BIO International Convention, J.P. Morgan Healthcare Conference, PULSE: The Atlantic Summit on Health Care, and MedCity CONVERGE.He currently serves as President, Chairman and CEO of Quanterix, a company digitizing biomarker analysis to advance precision health. In 2017, he took Quanterix public in one of the most successful IPOs for a life science tools company in recent history. Hrusovsky is renowned for his strong track record of launching disruptive technologies, building fast-growing companies, and developing successful commercialization strategies. He lends his business expertise on the boards of several innovative technology companies and serves on the Educational Board of the Massachusetts Biotech Council the JALA Editorial Board, the Strategy Committee of Children’s Hospital Boston and more.Hrusovsky holds an M.B.A. from Ohio University and a B.S. in Mechanical Engineering from The Ohio State University. He received an Honorary Doctorate from Framingham State University and helped build competitive strategy curriculum at the Institute for Strategy & Competitiveness at Harvard Business School. Follow him on Twitter @KevinHrusovsky.

David R. Walt Ph.d

Board Member

Keith L. Crandell

Board Member

Paul M. Meister

Board Member

Martin D. Madaus

Board Member

Masoud Toloue Ph.d

Chief Executive Officer

Masoud Toloue Ph.d's LinkedIn

Sarah E. Hlavinka McConnell

Board Member

Karen A. Flynn

Board Member

Laurie J. Olson

Board Member

Shawn Stetson

Interim CFO & Treasurer

Shawn Stetson's LinkedIn

Shawn Stetson is an Interim CFO & Treasurer at Quanterix and Senior Director/Controller at Quanterix and is based in Greater Boston Area. He has worked as Manager at EY, Consultant at FTI Consulting, and Senior Director/Corporate Controller at Quanterix. Shawn attended Northeastern University between 1999 and 2001 and Bowdoin College between 1995 and 1999.

Quanterix leadership demographics

Quanterix gender distribution in management team

  • The Quanterix executive team is 32% female and 68% male.
  • Quanterix is 6% female and 94% male company-wide.
Male
Male
68%
Company-wide: 94%
Female
Female
32%
Company-wide: 6%

Quanterix executives by race

Management Team:
  • The most common ethnicity among Quanterix executive officers is White.
  • 68% of the management team is White.
  • 11% of Quanterix's management is Black or African American.
  • 8% of the management team is Hispanic or Latino.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 60% of employees are White.
  • 25% of employees are Asian.
  • 7% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Quanterix jobs nearby

Quanterix executives FAQs

Zippia gives an in-depth look into the details of Quanterix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Quanterix. The employee data is based on information from people who have self-reported their past or current employments at Quanterix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Quanterix. The data presented on this page does not represent the view of Quanterix and its employees or that of Zippia.

Quanterix may also be known as or be related to QUANTERIX, QUANTERIX CORP, Quanterix, Quanterix Corp, Quanterix Corp. and Quanterix Corporation.